These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 32186222)
21. Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation. Campanati A; Goteri G; Simonetti O; Ganzetti G; Giuliodori K; Giuliano A; Sabato S; Stramazzotti D; Gulini E; Dusi D; De Blasio S; Fabris G; Offidani A Int J Immunopathol Pharmacol; 2009; 22(2):371-7. PubMed ID: 19505391 [TBL] [Abstract][Full Text] [Related]
22. Glucose transporter-1 (GLUT-1) expression in psoriasis: correlation with disease severity. Hodeib AA; Neinaa YME; Zakaria SS; Alshenawy HA Int J Dermatol; 2018 Aug; 57(8):943-951. PubMed ID: 29797802 [TBL] [Abstract][Full Text] [Related]
23. Expression of tachykinins and their receptors in plaque psoriasis with pruritus. Amatya B; El-Nour H; Holst M; Theodorsson E; Nordlind K Br J Dermatol; 2011 May; 164(5):1023-9. PubMed ID: 21299544 [TBL] [Abstract][Full Text] [Related]
24. Expression of p53 in lesions and unaffected skin of patients with plaque-type and guttate psoriasis: a quantitative comparative study. Yazici AC; Karabulut AA; Ozen O; Ekşioğlu M; Ustün H J Dermatol; 2007 Jun; 34(6):367-74. PubMed ID: 17535401 [TBL] [Abstract][Full Text] [Related]
25. Valosin-containing Protein in Psoriasis: A Clinical and Immunohistochemical Study. El Dein Mohamed AS; Hagag MM; Kassem NMAE; Shehata WA Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):e68-e72. PubMed ID: 33979096 [TBL] [Abstract][Full Text] [Related]
26. Lesional upregulation of SLURP1 immunostaining parallels disease severity in psoriasis vulgaris patients. Assaf M; Salah E J Dtsch Dermatol Ges; 2018 Nov; 16(11):1329-1337. PubMed ID: 30395407 [TBL] [Abstract][Full Text] [Related]
27. Inducibility and expression of microvascular endothelial adhesion molecules in lesional, perilesional, and uninvolved skin of psoriatic patients. Petzelbauer P; Pober JS; Keh A; Braverman IM J Invest Dermatol; 1994 Sep; 103(3):300-5. PubMed ID: 7521374 [TBL] [Abstract][Full Text] [Related]
28. Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin. Jiang WY; Chattedee AD; Raychaudhuri SP; Raychaudhuri SK; Farber EM Int J Dermatol; 2001 Nov; 40(11):699-703. PubMed ID: 11737436 [TBL] [Abstract][Full Text] [Related]
29. Prolactin level is significantly elevated in lesional skin of patients with psoriasis. El-Khateeb EA; Zuel-Fakkar NM; Eid SM; Abdul-Wahab SE Int J Dermatol; 2011 Jun; 50(6):693-6. PubMed ID: 21595663 [TBL] [Abstract][Full Text] [Related]
31. Inverse correlation between caveolin-1 expression and clinical severity in psoriasis vulgaris. Ma WY; Zhuang L; Cai DX; Zhong H; Zhao C; Sun Q J Int Med Res; 2012; 40(5):1745-51. PubMed ID: 23206456 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of OVOL1 and Filaggrin immunohistochemical expression and clinical relevance in psoriasis. Hemida AS; Hammam MA; Swilam AA; Shehata WA Diagn Pathol; 2024 Jun; 19(1):84. PubMed ID: 38907248 [TBL] [Abstract][Full Text] [Related]
33. Study of serum levels and skin expression of S100B protein in psoriasis. Salem SAM; El-Khateeb EA; Harvy M; Emam HME; Abdelaal W; Nemr RE; El-Hagry OO An Bras Dermatol; 2017; 92(3):323-328. PubMed ID: 29186242 [TBL] [Abstract][Full Text] [Related]